Pharmaceutical Companies Seek to Balance Quality Assurance & Cost Reduction
CHAPEL HILL, N.C., June 12 /PRNewswire/ -- Two-thirds of companies find that a vertical quality and compliance model effectively increases internal efficiencies compared to a horizontal model. However, according to a recent study by Best Practices, LLC's GLOBAL BENCHMARKING COUNCIL, having a single Q&C organization per function does not help reduce operating costs, an increasingly important challenge in today's economic landscape.
How efficient and effective are quality and compliance processes at your company?
Download a complimentary research briefing at http://www3.best-in-class.com/gr193.htm to view key study objectives, a list of benchmarked companies, selected key findings, commonly used quality and compliance management structures and their effectiveness, reorganization trends and more. This partner-driven primary research is an example of how we support quality executives with relevant metrics and best practices for strategic decision-making.
Recently Added Research for Partners include:
The Role of Regulatory Affairs in Preparing for NDA Interactions
Best Practices for Valuing Internal Consulting Organizations
M&A Integration Excellence: What Bio-Pharma Companies Need to Know
Skills, Capabilities and Competencies for Success in Regulatory Affairs
Safety and Risk Management in the Pharmaceutical Sector
Discuss your specific business dilemmas in a Guided Virtual Presentation of our decision support services with Elizabeth Winstead, director of solutions. Please sign up now at http://www3.best-in-class.com/gr179.htm to explore further the suite of research and networking opportunities available to you through a business partnership with the GLOBAL BENCHMARKING COUNCIL. For more information, contact her directly at 919.767.9259, [email protected].
Best Practices, LLC's GLOBAL BENCHMARKING COUNCIL (http://www3.best-in-class.com/gbc) is an innovative research, benchmarking and networking service for business executives in pharmaceutical and life sciences to promote top-line revenue growth, cost reduction and innovative problem-solving.
For more than a decade, executives have used GLOBAL BENCHMARKING COUNCIL competitive advantages, such as ready access to executives, fast-turnaround research efforts, expansive Best Practice Database and annual networking conferences to refine initiatives, request funding and allocate resources.